Akèy › Myelom Miltip › New York › Queens
Etid klinik pou Myelom Miltip nan Queens, NY
20 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- NYU Winthrop, Mineola · 11 mi lwen
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 3
- Northwell Health Cancer Institute, Lake Success · 9 mi lwen
- NYU Langone Hospital Long Island, Mineola · 11 mi lwen
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Ap rekriteFaz 3
- MSK Nassau, Uniondale · 13 mi lwen
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Queens Cancer Center, Rego Park · 3 mi lwen
- Cohen Children's Medical Center, New Hyde Park · 9 mi lwen
- Northwell Health Monter Cancer Center, Lake Success · 9 mi lwen
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Ap rekriteFaz 3
- Long Island Jewish Medical Center, New Hyde Park · 9 mi lwen
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi lwen
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Ap rekriteFaz 3
- MSK Nassau, Uniondale · 13 mi lwen
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Ap rekriteFaz 3
- Research Site, New Hyde Park · 9 mi lwen
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi lwen
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Ap rekriteFaz 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
A Dietary Study for People With Multiple Myeloma
Ap rekrite
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 mi lwen
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Ap rekrite
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan Queens
- Kansè nan tete63 etid
- Kansè Poumon ki pa ti selil49 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Kansè ovè28 etid
- Kansè pwostat27 etid
- Kansè (tout kalite)26 etid
- Kansè Endomèt25 etid
- Kansè poumon22 etid
- Leksemi mieloïd egi21 etid
- Karsinòm selil skuamèz tèt ak kou20 etid
- Kansè pankreyas20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.